Enigma Diagnostics Showcases the Enigma ML as a Service Provider at InnovHealth Summit 2010 in Abu Dhabi

OXFORD, England and SAN DIEGO, April 22 — Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it will be a product provider at the InnovHealth – Middle East Healthcare Innovations Summit in Abu Dhabi on 25 and 26 April 2010 and will be presenting the Enigma (“Mini Laboratory”) instrument system.

The Enigma ML is a fully automated, multi-sample, multi-plexing diagnostic instrument with integrated sample preparation and will deliver results from swab samples in less than 60 minutes, allowing clinical professionals to ‘test and treat’ in a single appointment. This simple to use system which requires minimal operator training, combines the speed and sensitivity of real-time PCR (polymerase chain reaction) to provide laboratory standard results.

InnovHealth 2010, organised by business information company naseba and endorsed by the UAE Ministry of Health, recognises Enigma as a pioneer in providing innovative healthcare solutions to the regions’ progressing healthcare industry. Facilitating strategic networking, the event hosts the region’s high-profile healthcare leaders, all of whom will benefit from informative conference sessions and panel discussions during the two-day summit.